Year |
Citation |
Score |
2007 |
Dovey M, Aitken ML, Emerson J, McNamara S, Waltz DA, Gibson RL. Oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbation: a pilot study. Chest. 132: 1212-8. PMID 17646219 DOI: 10.1378/Chest.07-0843 |
0.402 |
|
2006 |
Kalish LA, Waltz DA, Dovey M, Potter-Bynoe G, McAdam AJ, Lipuma JJ, Gerard C, Goldmann D. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 173: 421-5. PMID 16272450 DOI: 10.1164/Rccm.200503-344Oc |
0.351 |
|
2005 |
Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB. Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result. The Journal of Pediatrics. 147: S98-100. PMID 16202793 DOI: 10.1016/J.Jpeds.2005.08.007 |
0.621 |
|
2005 |
Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB. Challenges in implementing a successful newborn cystic fibrosis screening program. The Journal of Pediatrics. 147: S89-93. PMID 16202791 DOI: 10.1016/J.Jpeds.2005.08.006 |
0.579 |
|
2005 |
Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O'Sullivan BP. Sweat testing infants detected by cystic fibrosis newborn screening. The Journal of Pediatrics. 147: S69-72. PMID 16202787 DOI: 10.1016/J.Jpeds.2005.08.015 |
0.611 |
|
2004 |
Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics. 113: 1573-81. PMID 15173476 DOI: 10.1542/Peds.113.6.1573 |
0.607 |
|
2003 |
Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan MW, Moss R, Retsch-Bogart G, Wagener J, Waltz D, et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 167: 841-9. PMID 12480612 DOI: 10.1164/Rccm.200208-855Oc |
0.321 |
|
2001 |
Aitken ML, Moss RB, Waltz DA, Dovey ME, Tonelli MR, McNamara SC, Gibson RL, Ramsey BW, Carter BJ, Reynolds TC. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Human Gene Therapy. 12: 1907-16. PMID 11589832 DOI: 10.1089/104303401753153956 |
0.377 |
|
2001 |
Noone PG, Hamblett N, Accurso F, Aitken ML, Boyle M, Dovey M, Gibson R, Johnson C, Kellerman D, Konstan MW, Milgram L, Mundahl J, Retsch-Bogort G, Rodman D, Williams-Warren J, et al. Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study. Pediatric Pulmonology. 32: 122-8. PMID 11477729 DOI: 10.1002/Ppul.1098 |
0.329 |
|
1998 |
Sawyer SM, Tully MA, Dovey ME, Colin AA. Reproductive health in males with cystic fibrosis: knowledge, attitudes, and experiences of patients and parents. Pediatric Pulmonology. 25: 226-30. PMID 9590482 DOI: 10.1002/(Sici)1099-0496(199804)25:4<226::Aid-Ppul2>3.0.Co;2-I |
0.317 |
|
Show low-probability matches. |